HPR95 Participation in a Patient Support Program is Associated With Improved Access to Efgartigimod Treatment for Generalized Myasthenia Gravis in Patients Facing Social Determinants of Health (SDOH) Challenges
Abstract
Authors
Tom Hughes Dominic R. Nunag Avery Mohan Matthew Davis Glenn Phillips